Crown Castle International Corp. (NYSE:CCI) shares fell -0.37% in last trading session and ended the day at $85.67. CCI Gross Margin is 63.50% and its has a return on assets of 7.10%. Crown Castle International Corp. (NYSE:CCI) quarterly performance is 5.70%.
Crown Castle International Corp. (NYSE:CCI) has declared a quarterly cash dividend of $0.885 per common share. The quarterly dividend will be payable on December 31, 2015 to common stockholders of record at the close of business on December 18, 2015. Future dividends are subject to the approval of the Company’s Board of Directors.
Oceaneering International, Inc. (NYSE:OII) ended the last trading day at $42.13. Company weekly volatility is calculated as 4.05% and price to cash ratio as 21.63. Oceaneering International, Inc. (NYSE:OII) showed a weekly performance of -9.86%.
Oceaneering International, Inc. (NYSE:OII) revealed earnings for third quarter that fell from last year. The company said its earnings dropped to $68.54 million, or $0.70 per share. This was lower than $124.34 million, or $1.16 per share, in last year’s third quarter.
On 29 October, Facebook Inc (NASDAQ:FB) shares moved up 0.65% and was closed at $104.88. FB EPS growth in last 5 year was 78.90%. Facebook Inc (NASDAQ:FB) year to date (YTD) performance is 34.43%.
On 25 October, Facebook Inc (NASDAQ:FB) said that, it is making changes to its universal search feature and will now include all public posts in the results. Facebook made an official announcement is a press statement, pointing that the social network sees over 1.5 billion searches per day and indexes over 2 trillion posts.
Emerald Oil, Inc. (NYSEMKT:EOX) shares fell -2.08% in last trading session and ended the day at $1.88. EOX Gross Margin is 59.40% and its has a return on assets of -34.70%. Emerald Oil, Inc. (NYSEMKT:EOX) quarterly performance is 11.24%.
Emerald Oil, Inc. (NYSEMKT:EOX) said that, it plans to announce its third quarter 2015 financial and operational results on Wednesday, November 4, 2015 after the close of trading on the NYSE MKT. The Company will host a conference call on Thursday, November 5, 2015 at 9:30 a.m. Eastern Time to discuss financial and operational results for the quarter end.
Repros Therapeutics Inc. (NASDAQ:RPRX) caters to the Healthcare space. Its weekly performance is -61.41%. On the last day of trading company shares ended up at $2.08. Repros Therapeutics Inc. (NASDAQ:RPRX) distance from 50-day simple moving average (SMA50) is 4.03%.
Repros Therapeutics Inc. (NASDAQ:RPRX) announced that the Division of Bone, Reproductive and Urologic Products of the U.S. Food and Drug Administration (FDA) has cancelled the scheduled November 3, 2015 advisory committee to review the Company’s New Drug Application (NDA) for its enclomiphene product candidate, formerly known as Androxal®, due to questions that arose late in the review regarding the bioanalytical method validation that could affect interpretability of certain pivotal study data.
Leave a Reply